[Hepatocellular carcinoma in undamaged liver]

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Hepatocellular Carcinoma Research

Context:

• Hepatocellular carcinoma (HCC) typically affects patients with liver cirrhosis or fibrosis.
• A subset of HCC, non fibrolamellar HCC (NF-HCC), can arise in normal liver parenchyma.
• Understanding outcomes for NF-HCC in non-cirrhotic livers is crucial for treatment strategies.

Purpose:

• To evaluate the outcomes of hepatic resection for non fibrolamellar hepatocellular carcinoma in patients without underlying liver disease.
• To assess survival rates, recurrence patterns, and the efficacy of aggressive surgical management for this specific HCC subtype.
• To determine if surgical intervention is warranted for NF-HCC originating in a normal liver.

Summary:

• This study analyzed 12 patients with non fibrolamellar HCC in normal livers who underwent hepatic resection between 1979 and 1990.
• Tumor characteristics included absence of Hepatitis B surface antigen, low alphafetoprotein levels (<100 mg/ml) in 83%, and presence of a capsule in 83%.
• Actuarial survival rates at 3 and 5 years were 57% and 38%, respectively, with recurrence observed in 67% of patients. Despite recurrence, two patients survived long-term after further treatment.

Impact:

• The findings suggest that aggressive surgical resection is a viable and justified approach for non fibrolamellar hepatocellular carcinoma in patients with normal livers.
• This study contributes to the understanding of NF-HCC management, highlighting the potential for long-term survival even after recurrence.
• Results support the consideration of extensive surgical intervention for this rare presentation of HCC.